002411 On Other Exchanges
Symbol
Exchange
Shenzhen

jiangsu bicon pharmaceutic-a (002411) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for JIANGSU BICON PHARMACEUTIC-A (002411)
\

Related News

No related news articles were found.

jiangsu bicon pharmaceutic-a (002411) Related Businessweek News

No Related Businessweek News Found

jiangsu bicon pharmaceutic-a (002411) Details

YanAn Bicon Pharmaceutical Listed Company researches and develops, produces, and sells pharmaceutical intermediates, pesticide intermediates, and new energy and materials products in China and internationally. It offers 7-ADCA; 5,5-dimethylhydantoin; 5,5-dimethyl hydantoin; sodium trichloropyridine; 3,5,6-trichloropyridin-2-ol sodium; lithium hexafluorophosphate; lithium battery separators; membrane for lithium-ion batteries; polyethylene fiber products; and UHMWPE fiber products. The company was formerly known as JiangSu Bicon Pharmaceutical Listed Company and changed its name to YanAn Bicon Pharmaceutical Listed Company in October 2018. The company was founded in 2002 and is based in Nantong, China. YanAn Bicon Pharmaceutical Listed Company is a subsidiary of Xinyi Bicon New Medicine Industry Complex Investment Co., Ltd.

4,946 Employees
Last Reported Date: 04/28/19
Founded in 2002

jiangsu bicon pharmaceutic-a (002411) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jiangsu bicon pharmaceutic-a
YanAn Bicon Pharmaceutical Listed Company Proposes Amendments to Articles of Association

YanAn Bicon Pharmaceutical Listed Company proposed Amendments to the Company's articles of association at its 2018 Annual General Meeting to be held on June 14, 2019.

Yanan Bicon Pharmaceutical Listed Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2018

YanAn Bicon Pharmaceutical Listed Company announced earnings results for the fourth quarter ended December 31, 2018. For the fourth quarter, the company announced For the full year, sales was CNY 8,446.807 million compared to CNY 5,368.005 million a year ago. Operating income was CNY 609.939 million compared to CNY 1,083.872 million a year ago. Net income was CNY 404.193 million compared to CNY 892.625 million a year ago. Basic earnings per share from continuing operations was CNY 0.2638 compared to CNY 0.5825 a year ago. Sales was CNY 2,061.930 million compared to CNY 1,815.810 million a year ago. Operating income was CNY 197.100 million compared to CNY 257.673 million a year ago. Net income was CNY 154.697 million compared to CNY 215.865 million a year ago. Basic earnings per share from continuing operations was CNY 0.101 compared to CNY 0.1409 a year ago. Sales was CNY 277.801 million compared to CNY 158.516 million a year ago. Operating income was CNY 29.087 million compared to CNY 9.392 million a year ago. Net income was CNY 21.990 million compared to CNY 7.639 million a year ago. Basic earnings per share from continuing operations was CNY 0.1144 compared to CNY 0.0398 a year ago.

YanAn Bicon Pharmaceutical Listed Company to Report Fiscal Year 2018 Results on Apr 29, 2019

YanAn Bicon Pharmaceutical Listed Company announced that they will report fiscal year 2018 results on Apr 29, 2019

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

002411 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002411.
View Industry Companies
 

Industry Analysis

002411

Industry Average

Valuation 002411 Industry Range
Price/Earnings 82.9x
Price/Sales 3.3x
Price/Book 2.9x
Price/Cash Flow 82.9x
TEV/Sales 2.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact JIANGSU BICON PHARMACEUTIC-A, please visit www.jjjkj.com.cn. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.